Hepatocellular Carcinoma Caused by Hepatitis B Virus

  • Joseph L. Melnick

Abstract

Although hepatocellular carcinoma (HCC) is rare in Europe and North America, it is very common in many areas of the world, especially in Africa and southeast Asia, where it is among the ten most common human cancers. It is estimated that there are more than 500,000 new patients with liver cancer each year. Over 30 new cases of hepatoma occur per 100,000 population annually in the high-prevalence areas, but the yearly incidence is less than 5 per 100,000 in most countries of North America, Europe, and Australia. Hepatocellular carcinoma is more common in males than among females. Its prevalence increases with age, although in high-risk populations, the disease also occurs in younger age groups.

Keywords

Hepatocellular Carcinoma Ground Squirrel Primary Liver Cancer Primary Hepatocellular Carcinoma Pekin Duck 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arevalo, J. A. And Washington, A. E., Cost-effectiveness of prenatal screening and immunization for hepatitis B virus, J.A.M.A. 259:365–369 (1988).Google Scholar
  2. 2.
    Beasley, R. P. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations, Hepatology 2:21S–26S (1982).Google Scholar
  3. 3.
    Beasley, R. P., and Hwang, L.-Y., Epidemiology of hepatocellular carcinoma, in: Viral Hepatitis and Liver Disease (G. N. VYAS, J. L. DIENSTAG, AND J. H. HOOFNAGLE, EDS.), pp. 209–224, Grune und Stratton, Orlando, FL, 1984.Google Scholar
  4. 4.
    Beasley, R. P. Hwang, L.-Y., Lin, C.-C., and Chien, C.-S., Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan, Lancet 2:1129–1133 (1981).Google Scholar
  5. 5.
    Beasley, R. P., Hwang, L.-Y., Stevens, C. E., Lin, C.-C., Hsieh, F.-J., Wang, K.-Y., Sun, T. S., and Szmuness, W., Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: Final report of a randomized double-blind, placebo-controlled trial, Hepatology 3: 135–141 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    Beasley, R. E, Trepo, C., Stevens, C. E., and Szmuness, W., The e antigen and vertical transmission of hepatitis B surface antigen, Am. J. Epidemiol. 105: 94–98 (1977).PubMedGoogle Scholar
  7. 7.
    Blumberg, B. S., And London, W. T., Hepatitis B virus and primary hepatocellular carcinoma: Relationship of “icrons” to cancer, in: Viruses in Naturally Occurring Cancers (M. ESSEX, G. TODARO, AND H. ZUR HAUSEN, EDS.), pp. 401–421, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1980.Google Scholar
  8. 8.
    Blumberg, B. S., And London, W. T., Hepatitis B virus and the prevention of primary cancer of the liver, J. Natl. Cancer Inst. 74: 267–273 (1985).PubMedGoogle Scholar
  9. 9.
    Brechot, C., Pourcel, C., Louise, A., Rain, B., And Tiollais, P., Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma, Nature 285: 533–535 (1980).CrossRefGoogle Scholar
  10. 10.
    Butu, J., Miller, R H, Kew, M. C., And Purcell, R. H., Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma, Proc. Natl. Acad. Sci. USA 90: 1848–1851 (1993).CrossRefGoogle Scholar
  11. 11.
    Caselmann, W. H., Meyer, M., Kekule, A. S., Lauer, U., Hofschneider, P. H., And Kochy, R., A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA, Proc. Natl. Acad Sci USA 87: 2970–2974 (1990).PubMedCrossRefGoogle Scholar
  12. 12.
    Chen, D. S., Hoyer, B. H., Nelson, J., Purcell, R. H., And Gerin, J. L., Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma, Hepatology 2: 42S - 46S (1982).Google Scholar
  13. 13.
    Chisari, F. V., Filippi, P., Mclachlan, A., Milich, D. R., Riggs, M., Lee, S., Palmiter, R. D., Pinkert, C. A., And Brinster, R. L., Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice, J. Virol. 60: 880–887 (1986).PubMedGoogle Scholar
  14. 14.
    Coursaget, P., Leboulleux, D., Cann, P. LE, Bao, O., And Coll-Seck, A. M., Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal, Trans. R. Soc. Trop. Med. Hyg. 86: 552–553 (1992).PubMedCrossRefGoogle Scholar
  15. 15.
    Cutler, S. J., And Young, J. L., JR., Third National Cancer Survey. Incidence data, in: NCI Monograph 41, DHEW Publication No. (NIH) 75–785, NCI, Bethesda, MD, 1975.Google Scholar
  16. 16.
    Dejean, A., Bougueleret, L., Grzeschik, K.-H., And Tiollais, P., Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma, Nature 322: 70–72 (1986).PubMedCrossRefGoogle Scholar
  17. 17.
    Dejean, A., Brechot, C., Tiollais, P., And Wain-Hobson, S., Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5, Proc. Natl. Acad. Sci. USA 80: 2505–2509 (1983).PubMedCrossRefGoogle Scholar
  18. 18.
    Dejean, A., Sonigo, P., Wain-Hobson, S., And Tiollais, P, Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat, Proc. Natl. Acad. Sci. USA 81: 5350–5354 (1984).PubMedCrossRefGoogle Scholar
  19. 19.
    De The, H., Marchio A., Tiollais, P., And Dejean, A., A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma, Nature 330: 667–670 (1987).PubMedCrossRefGoogle Scholar
  20. 20.
    Fourel, G., Trepo, C., Bougueleret, L., Hengleins, B., Ponzetto, A., Tiollais, R, And Buendia, M.-A., Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours, Nature 347: 294–298 (1990).PubMedCrossRefGoogle Scholar
  21. 21.
    Ganem, D., And Varmus, H. E., The molecular biology of the hepatitis B viruses, Annu. Rev. Biochem. 56: 651–693 (1987).PubMedCrossRefGoogle Scholar
  22. 22.
    Gerin, J. L., Tennant, B. C., Ponzetto, A., Purcell, R. H., And Tyeryar, F. J., The woodchuck animal model of hepatitis B-like virus infection and disease, Prog. Clin. Biol. Res. 143: 23–28 (1983).PubMedGoogle Scholar
  23. 23.
    Goudeau, A., Maupas, R, Coursaget, P, Drucker, J., Chiron, J.-R, Denis, F., Mar, I. D., And N’diaye, P. D., Detection of hepatitis B virus antigens in hepatocellular carcinoma tissues, Prog. Med. Virol. 27: 77–87 (1981).PubMedGoogle Scholar
  24. 24.
    Harrison, T. J., Chen, J.-Y., And Zuckerman, A. J., Hepatitis B and primary liver cancer, in: Cancer Treatment Reviews, Vol. 13 (K. HELLMANN AND S. K. CARTER, EDS.), pp. 1–16, Academic Press, London, 1986.Google Scholar
  25. 25.
    Hind, O., Kitagawa, T., Koike, K., Kobayashi, M., Hara, M., Mori, W., Nakashima, T., Hattori, N., And Sugano, H., Detec-tion of hepatitis B virus DNA in hepatocellular carcinomas in Japan, Hepatology 4: 90–95 (1984).CrossRefGoogle Scholar
  26. 26.
    Hsia, C. C., Kleiner, D. E., JR., Axiotis, C. A., Bisceglie, A. D., Nomura, A. M. Y., Stemmermann, G. N., And Tabor, E., Mutations of p53 gene in hepatocellular carcinoma: Roles of hepatitis virus and aflatoxin contamination in the diet, J. Natl. Cancer Inst. 84: 1638–1641 (1992).PubMedCrossRefGoogle Scholar
  27. 27.
    Hsu, T.-Y, Moroy, T., Etiemble, J., Louise, A., Trepo, C., Tiollais, P., And Buendia, M.-A., Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma, Cell 55: 627–635 (1988).PubMedCrossRefGoogle Scholar
  28. 28.
    Kane, M. A., Hadler, S. C., Margolis, H. S., And Maynard, J. E., Routine prenatal screening for hepatitis B surface antigen, J.A.M.A. 259:408–409 (1988).Google Scholar
  29. 29.
    Kekule, A. S., Lauer, U., Weiss, L., Luber, B., And Hofschneider, P. H., Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway, Nature 361: 742–745 (1993).PubMedCrossRefGoogle Scholar
  30. 30.
    Kim, C. M., Koike, K., Saito, I., Miyamura, T., And Jay, G., HBx gene of hepatitis B virus induces liver cancer in transgenic mice, Nature 351: 317–320 (1991).PubMedCrossRefGoogle Scholar
  31. 31.
    Koshy, R., Koch, S., Von Loringhoven, A. F., Kahmann, R., Murray, K., And Hofschneider, R H., Integration of hepatitis B virus DNA: Evidence for integration in the single-stranded gap, Cell 34: 215–223 (1983).PubMedCrossRefGoogle Scholar
  32. 32.
    Larouze, B., London, W. T., Saimot, G., Werner, B. G., Lustbader, E. D., Payet, M., And Blumberg, B. S., Host re-sponses to hepatitis-B infection in patients with primary hepatic carcinoma and their families: A case-control study in Senegal, West Africa, Lancet 2: 534–538 (1976).PubMedCrossRefGoogle Scholar
  33. 33.
    Lee, T.-H., And Butel, J. S., Trans-activation of the HBV enhancer by the X gene of HBV, in: Abstracts of the Conference on Hepatitis B Viruses, p. 19, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1987.Google Scholar
  34. 34.
    Lee, T.-H., Finegold, M. J., Shen, R.-F., Demayo, J. L., Woo, S. L. C., And Butel, J. S., Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice, J. Virol. 64: 5939–5947 (1990).PubMedGoogle Scholar
  35. 35.
    Liu, C. B., XU, Z. Y., Cao, H. L., Sun, Y. D., Jing, Q., Cheng, D. B., Chen, M. H., And Xie, Y. F., A field study of the incidence of acute and chronic viral hepatitis and the mortality of hepatitis-related diseases and hepatocellular carcinoma, Chin. J. Virol. 1 (Suppl.): 1–8 (1991).Google Scholar
  36. 36.
    Marion, P. L., Use of animal models to study hepatitis B virus, Prog. Med. Virol. 35: 43–75 (1988).PubMedGoogle Scholar
  37. 37.
    Marion, R L., Knight, S. S., Salazar, E H., Popper, H., And Robinson, W. S., Ground squirrel hepatitis virus infection, Hepatology 3: 519–527 (1983).PubMedCrossRefGoogle Scholar
  38. 38.
    Marion, R L., Oshiro, L. S., Regnery, D. C., Scullard, G. H., And Robinson, W. S., A virus in Beechey ground squirrels that is related to hepatitis B virus of humans, Proc. Natl. Acad. Sci. USA 77: 2941–2945 (1980).PubMedCrossRefGoogle Scholar
  39. 39.
    Marion, R. L., And Robinson, W. S., Hepadna viruses: Hepatitis B and related viruses, Curr. Top. Microbiol. Immunol. 105: 91–121 (1983).Google Scholar
  40. 40.
    Marion, R L., Van Davelaar, M. J., Knight, S. S., Salazar, F. H., Garcia, G., Popper, H., And Robinson, W. S., Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus, Proc. Natl. Acad. Sci. USA 83: 4543–4546 (1986).PubMedCrossRefGoogle Scholar
  41. 41.
    Mason, W. S., Seal, G., And Summers, J., A virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus, J. Virol. 36: 829–836 (1980).PubMedGoogle Scholar
  42. 42.
    Maupas, R, Chiron, J.-P., Goudeau, A., Coursaget, R, Per-Rin, J., Barin, E, Denis, E, And Mar, B. D., Active immunization against hepatitis B in an area of high endemicity. Part II: Prevention of early infection of the child, Prog. Med. Virol. 27: 185–201 (1981).PubMedGoogle Scholar
  43. 43.
    Maupas, P., And Melnick, J. L. (EDs.), Hepatitis B virus and primary hepatocellular carcinoma, Prog. Med. Viral. 27: 1–210 (1981).Google Scholar
  44. 44.
    Maupas, R, And Melnick, J. L., Hepatitis B infection and primary liver cancer, Prog. Med. Virol. 27: 1–5 (1981).PubMedGoogle Scholar
  45. 45.
    Mcauliffe, V. J., Purcell, R H., And Gerin, J. L., Type B hepatitis: A review of current prospects for a safe and effective vaccine, Rev. Infect. Dis. 2: 470–492 (1980).PubMedCrossRefGoogle Scholar
  46. 46.
    Melnick, J. L., Hepatitis B virus and liver cancer, in: Viruses Associated with Human Cancer (L. A. PHILLIPS, ED.), pp. 337367, Marcel Dekker, New York, 1983.Google Scholar
  47. 47.
    Melnick, J. L., And Ledinko, N., Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period. The ratio of inapparent infection to clinical poliomyelitis, Am. J. Hyg. 58: 207–222 (1953).PubMedGoogle Scholar
  48. 48.
    Miyaki, M., Sato, C., Gotanda, T., Matsui, T., Mishiro, S., Imai, M., And Mayumi, M., Integration of region X of hepatitis B virus genome in human primary hepatocellular carcinomas propagated in nude mice, J. Gen. Virol. 67: 1449–1454 (1986).PubMedCrossRefGoogle Scholar
  49. 49.
    Nishioka, K., Levin, A. G., And Simons, M. J., Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease: Results of a collaborative study, Bull. WHO 521: 293–300 (1975).Google Scholar
  50. 50.
    Nishioka, K., Watanabe, J., Furuta, S., Tanaka, E., Iino, S., Suzuki, H., Tsuji, T., Yano, M., Kuo, G., Choo, Q. L., Houghton, M., And Oda, T., A high prevalence of antibody to hepatitis C virus in patients with hepatocellular carcinoma in Japan, Cancer 67: 429–433 (1991).PubMedCrossRefGoogle Scholar
  51. 51.
    Ochiya, T., Fujiyama, A., Fukushige, S., Hatada, I., and Mat-Subara, K., Molecular cloning of an oncogene from a human hepatocellular carcinoma, Proc. Natl. Acad. Sci. USA 83: 49934997 (1986).Google Scholar
  52. 52.
    Okada, K., Kamiyama, I., Inomata, M., Lmai, M., Miyakawa, Y., And Mayumi, M., E antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants, N. Engl. J. Med. 294: 746–749 (1976).PubMedCrossRefGoogle Scholar
  53. 53.
    Okada, K., And Beasley, R. P., Epidemiology of hepatocellular carcinoma, UICC Rep. 17: 9–30 (1982).Google Scholar
  54. 54.
    Popper, H., Roth, L., Purcell, R. H., Tennant, B. C., And Gerin, J. L., Hepatocarcinogenicity of the woodchuck hepatitis virus, Proc. Natl. Acad. Sci. USA 84: 866–870 (1987).PubMedCrossRefGoogle Scholar
  55. 55.
    Popper, H., Shafritz, D. A., And Hoofnagle, J. H., Relation of the hepatitis B virus carrier state to hepatocellular carcinoma, Hepatology 7: 764–772 (1987).PubMedCrossRefGoogle Scholar
  56. 56.
    Popper, H., Shin, J. W. K., Gerin, J. L., Wong, D. C., Hoyer, B. H., London, W. T., Sly, D. L., And Purcell, R. H., Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologie observations, Hepatology 1: 91–98 (1981).PubMedCrossRefGoogle Scholar
  57. 57.
    Prince, A. M., Discussion, in: Viral Hepatitis (G. N. VYAS, S. N., COHEN, AND R. SCHMID, EDS.), pp. 460–463, Franklin Institute Press, Philadelphia, 1978.Google Scholar
  58. 58.
    Prince, A. M., Hepatitis B virus and primary liver cancer, in: Accomplishments in Cancer Research, pp. 110–118, J. B. Lippincott, Philadelphia, 1985.Google Scholar
  59. 59.
    Robinson, W. S., Hepatitis B virus, in: Virology (B. N. Fields, D. M. Knipe, R. M. Chanock, J. L. Melnick, B. Roizman, And R. E. Shope, Ens.), pp. 1384–1406, Raven Press, New York, 1985.Google Scholar
  60. 60.
    Robinson, W. S., Marion, R, Feitelson, M., and Siddiqui, A., The hepadna virus group: Hepatitis B and related viruses, in: Viral Hepatitis-1981 International Symposium (W. SZMUNESS, H. J. ALTER, AND J. E. MAYNARD, EDS.), pp. 57–68, Franklin Institute Press, Philadelphia, 1982.Google Scholar
  61. 61.
    Rogler, C. E., Sherman, M., SU, C. Y., Shafritz, D. A., Summers, J., Shows, T. B., Henderson, A., And Kew, M., Deletion in chromosome lip associated with a hepatitis B integration site in hepatocellular carcinoma, Science 230: 319–322 (1985).PubMedCrossRefGoogle Scholar
  62. 62.
    Rossner, M. T., Review: Hepatitis B virus x-gene product: A promiscuous transcriptional activator, J. Med. Virol. 36: 101–117 (1992).PubMedCrossRefGoogle Scholar
  63. 63.
    Saracci, R., and Repetto, F., Time-trends of primary liver cancer: Indication of increased incidence in selected cancer registry populations, J. Natl. Cancer Inst. 65: 241–247 (1980).PubMedGoogle Scholar
  64. 64.
    Schweitzer, I. L., Infection of neonates and infants with the hepatitis B virus, Prog. Med. Virol. 20: 27–48 (1975).PubMedGoogle Scholar
  65. 65.
    Scorsone, K. A., Zhou, Y.-Z., Butel, J. S., And Slagle, B. L., p.53 Mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China, Cancer Res. 52: 1635–1638 (1992).Google Scholar
  66. 66.
    Shafritz, D. A., Shouval, D., Sherman, H. I., Hadziyannis, S. J., And Kew, M. C., Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens, N. Engl. J. Med. 305: 1067–1073 (1981).PubMedCrossRefGoogle Scholar
  67. 67.
    Sherlock, S., Diseases of the Liver and Biliary System, 6th ed., Blackwell, Boston, 1981.Google Scholar
  68. 68.
    Slagle, B. L., Lee, T.-H., And Butel, J. S., Hepatitis B virus and hepatocellular carcinoma, Prog. Med. Virol. 39: 167–203 (1992).PubMedGoogle Scholar
  69. 69.
    Slagle, B. L., Zhou, Y.-Z., And Butel, J. S., Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas, Cancer Res. 51: 49–54 (1991).PubMedGoogle Scholar
  70. 70.
    Soman, N. R., And Wogan, G. N., Activation of the c-Kir-ras oncogene in aflatoxin Bt-induced hepatocellular carcinoma and adenoma in the rat: Detection by denaturing gradient gel electrophoresis, Proc. Natl. Acad. Sci. USA 90: 2045–2049 (1993).PubMedCrossRefGoogle Scholar
  71. 71.
    Stevens, C. E., Beasley, R. R, Tsul, J., And Lee, W. C., Vertical transmission of hepatitis B antigen in Taiwan, N. Engl. J. Med. 292: 771–774 (1975).PubMedCrossRefGoogle Scholar
  72. 72.
    Summers, J., Three recently described animal virus models for human hepatitis B virus, Hepatology 1: 179–183 (1981).PubMedCrossRefGoogle Scholar
  73. 73.
    Summers, J., Smolec, J. M., And Snyder, R., A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks, Proc. Natl. Acad. Sci. USA 75: 4533–4537 (1978).PubMedCrossRefGoogle Scholar
  74. 74.
    Sun, T.-T., Chu, Y-R., Hsia, C.-C., Wei, Y.-P., And WU, S.-M., Strategies and current trends of etiologic prevention of liver cancer. UCLA Symp. Mol. Cell. Biol. 40: 283–292 (1986).Google Scholar
  75. 75.
    Sun, T.-T., Chu, Y-R., NI, Z.-Q., LU, J.-H., Huang, E, NI, Z.-P., Pei, X.-F., Yu, Z.-I., And Lw, G.-T., A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine, J. Cell. Physiol. 4 (Suppl.): 83–90 (1986).Google Scholar
  76. 76.
    Szmuness, W., Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association, Prog. Med. Virol. 24: 40–69 (1978).PubMedGoogle Scholar
  77. 77.
    Szmuness, W., Stevens, C. E., Ikram, H., M.ch, M. I., Harley, E. J., And Hollinger, F. B., Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans, J. Infect. Dis. 1.37: 822–829 (1978).Google Scholar
  78. 78.
    Tabor, E., Gerety, R. J., Vogel, C. L., Bayley, A. C., Anthony, P. P., Chan, C. H., And Barker, L. F., Hepatitis B virus infection and primary hepatocellular carcinoma, J. Natl. Cancer Inst. 58:1197–1200 (1977).Google Scholar
  79. 79.
    Tabor, E., And Kobayashi, K., Hepatitis C, a causative infectious agent of non-A, non-B hepatitis: Prevalence and structure-summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma, J: Natl. Cancer Inst. 84: 86–90 (1992).CrossRefGoogle Scholar
  80. 80.
    Tang, Z. Y., Wu, M. C., And Xia, S. S., Primary Liver Cancer, Springer, Berlin, 1989.Google Scholar
  81. 81.
    Tong, M. J., Thursby, M. W., Lin, J.-H., Weissman, J. V., And Mcpeak, C. M., Studies on the maternal-infant transmission of the hepatitis B virus and HBV infection within families, Prog. Med. Virol. 27: 137–147 (1981).PubMedGoogle Scholar
  82. 82.
    Twu, J.-S., And Schloemer, R. H., Transcriptional trans-activating function of hepatitis B virus, J. Virol. 61: 3448–3453 (1987).PubMedGoogle Scholar
  83. 83.
    Van Rensberg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van Der Watt, J. J., Vincent, T. J., And Purchase, I. E, Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei, Br. J. Cancer 51: 713–726 (1985).CrossRefGoogle Scholar
  84. 84.
    Wang, J., Chenivesse, X., Henglein, B., And Brechot, C., Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma, Nature 343: 555–557 (1990).PubMedCrossRefGoogle Scholar
  85. 85.
    Waterhouse, J., Mum, C., And Correa, P. (Ens.), Cancer Incidence in Five Continents, Vol. 3, IARC Publication No. 15, IARC, Lyon, France, 1976.Google Scholar
  86. 86.
    Wei, Y., Fourel, G., Ponzetto, A., Silvestro, M., Tiollais, P., And Buendia, M.-A., Hepadnavirus integration: Mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors, J. Virol. 66: 5265–5278 (1992).PubMedGoogle Scholar
  87. 87.
    Wen, Y-M., Xu, Z.-Y, Melnick, J. L. (EDs.) Viral hepatitis in China: Problems and control strategies, Monogr. Viral. 19: 1–159 (1992).Google Scholar
  88. 88.
    Wild, C. P., Shrestha, S. M., Anwar, W. A., And Montesano, R., Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in the Gambia and Thailand, Toxicol. Lett. 64/65: 455–461 (1992).Google Scholar
  89. 89.
    Yaginuma, K., Kobayashi, H., Kobayashi, M., Morishima, T., Matsuyama, K., And Koiice, K., Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children, J. Virol. 61: 1808–1813 (1987).PubMedGoogle Scholar
  90. 90.
    Yeh, F.-S., And Shen, K.-N., Epidemiology and early diagnosis of primary liver cancer in China, Adv. Cancer Res. 47: 297–329 (1986).CrossRefGoogle Scholar
  91. 91.
    Yeh, F. S., Yu, M. C., Mo, C. C., Luo, S., Tong, M. J., And Henderson, B. E., Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China, Cancer Res. 49: 25062509 (1989).Google Scholar
  92. 92.
    Yu, M.-W., You, S. L., Chang, A.-S., Lu, S.-N., Liaw, Y-E, And Chen, C.-J., Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan, Cancer Res. 51: 5621–5625 (1991).PubMedGoogle Scholar
  93. 93.
    Zavitsanos, X., Hatzakis, A., Kaklamani, E., Tzonou, A., Toupadaki, N., Broeksma, C., Chrispeels, J., Troonen, H., Hadziyannis, S., Hsieh, C.-C., Alter, H., And Trichopoulos, D., Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and nonstructural hepatitis C virus peptides, Cancer Res. 52: 5364–5367 (1992).PubMedGoogle Scholar
  94. 94.
    Zhou, Y-Z., Butel, J. S., LI, P.-J., Finegold, M. J., And Melnick, J. L., Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China, J. Natl. Cancer Inst. 79: 223–231 (1987).Google Scholar
  95. 95.
    Zhou, Y-Z., Slagle, B. L., Donehower, L. A., Van Tuinen, P., Ledbetter, D. H., And Butez, J. S., Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma, J. Virol. 62: 4224–4231 (1988).PubMedGoogle Scholar
  96. 96.
    Ziemer, M., Garcia, P., Shaul, Y, And Rutter, W. J., Sequence of hepatitis B virus DNA incorporated into the genome of a human hepatoma cell line, J. Virol. 53: 885–892 (1985).PubMedGoogle Scholar

Suggested Reading

  1. Beasley, R. P., And Hwang, L.-Y., Epidemiology of hepatocellular carcinoma, in: Viral Hepatitis and Liver Disease (G. N. Vyas, J. L. Dienstag, And J. H. Hoofnagle, Eds.), pp. 209–224, Grune und Stratton, Orlando, FL, 1984.Google Scholar
  2. Blumberg, B. S., And London, W. T., Hepatitis B virus and primary hepatocellular carcinoma: Relationship of “icrons” to cancer, in: Viruses in Naturally Occurring Cancers (M. Essex, G. Todaro, And H. Zur Hausen, Eds.), pp. 401–421, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1980.Google Scholar
  3. Harrison, T. J., Chen, J.-Y., And Zuckerman, A. J., Hepatitis B and primary liver cancer, in: Cancer Treatment Reviews, vol. 13 (K. Hellerman And S. K. Carter, EDS.), pp. 1–16, Academic Tress, London, 1986.Google Scholar
  4. Maupas, P., And Melnick, J. L. (EDS.), Hepatitis B virus and primary hepatocellular carcinoma, Prog. Med. V irol. 27: 1–210 (1981).Google Scholar
  5. Melnick, J. L., Hepatitis B virus and liver cancer, in: Viruses Associated with Human Cancer (L. A. Phillips, ED.), pp. 337–367, Marcel Dekker, New York, 1983.Google Scholar
  6. Wen, Y.-M., Xu, Z.-Y, And Melnick, J. L., Viral hepatitis in China: Problems and control strategies, Monogr. Virol. 19: 1–159 (1992).Google Scholar
  7. Yeh, E-S., And Shen, K.-N., Epidemiology and early diagnosis of primary liver cancer in China, Adv. Cancer Res. 47: 297–329 (1986).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Joseph L. Melnick
    • 1
  1. 1.Division of Molecular VirologyBaylor College of MedicineHoustonUSA

Personalised recommendations